Cadence, the health tech company helping health systems deliver world-class care to consumers at home throughout the U.S., has raised $100 million in Series B funding. The round was led by Coatue Management, with existing company investors including General Catalyst and Thrive Capital participating. The funding will accelerate the development of Cadence’s platform to provide data-driven, responsive, and personalized care in the home regardless of address.
Since its launch in 2021, Cadence’s national health system partners are increasing consumer agency and access to care in rural communities by promptly and safely getting consumers with congestive heart failure on Guideline Directed Medical Therapy. Cadence’s proprietary platform, a protocol-driven remote consumer monitoring program, supports improved clinical outcomes and quality of life for its consumers.
Building on the momentum of these early clinical results, Cadence is scaling its remote care platform with the leading national health systems to support consumers in the prevention, monitoring, and management of the costliest ongoing conditions affecting Americans’ health. Cadence is built to manage an increasing number of conditions, acuities, and care pathways, and is engineered to get smarter over time.
Cadence is a pioneering health technology company helping the nation’s most consumer-centric health systems deliver world-class care outside of the four walls of the hospital. Cadence’s Care in Sync™ platform couples powerful new technology with clinical excellence, providing its consumers a precise and personal level of care through remote consumer monitoring and virtual care.
This was reported by Cadence on December 14, 2021.
Contact information: Caitlyn Durcan, Press Contact, Cadence Solutions, Inc., 295 Lafayette Street, 7th Floor, New York, New York 10012; Email: email@example.com; Website: https://www.cadence.care/